MedTrace Logo

The Corona and COVID-19 Study in Telemark and Agder

NCT04514003 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-11-29

No results posted yet for this study

Summary

Through SARS-CoV-2 IgG testing of PCR positive and negative cases the study will follow the COVID-19 immune response by monitoring the SARS-CoV-2 IgG antibody levels over a period of two years. Further, risk factors will be identified by the use of the test-negative design including population controls, allowing comparison of participants with positive and negative tests, and with population controls (triangulation). Special emphasis will be on high risk groups in general and on different occupational, environmental and socio-economic groups in particular. Finally, severity of illness, deaths and the use of health care during will be assessed using national register data from Telemark and Agder.

Conditions

  • Covid19

Sponsors & Collaborators

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Norwegian Institute of Public Health

    collaborator OTHER_GOV

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Leiden University

    collaborator OTHER

  • Aalborg University

    collaborator OTHER

  • Sykehuset Telemark

    lead OTHER_GOV

Principal Investigators

  • Anne Kristin M. Fell, PhD · Sykehuset Telemark

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2026-12-31
Completion
2035-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04514003 on ClinicalTrials.gov